H.C. Wainwright analyst Amit Dayal lowered the firm’s price target on Aspen Aerogels to $20 from $30 and keeps a Buy rating on the shares. The company’s revenue outlook for 2024 came in lower than expectations, the analyst tells investors in a research note. However, the firm remains impressed with the roughly 47% revenue growth expected in 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ASPN: